Dengue 2 Virus Envelope Protein Expressed by a Recombinant Vaccinia Virus Fails to Protect Monkeys Against Dengue
Overview
Affiliations
A cDNA copy of the dengue (DEN) 2 virus genome region encoding the virion capsid, membrane and envelope structural proteins has been inserted into vaccinia virus (VV) DNA under the control of its 11K late promoter. The DEN-2 envelope protein was expressed and processed in cells infected with the VV recombinant (VV/D2S). No DEN-2 virus antibody response was detected in mice, hamsters or monkeys vaccinated with VV/D2S. Furthermore, a viraemia was observed in recombinant-vaccinated monkeys after challenge with infectious DEN-2 virus.
Genetic Adaptation by Dengue Virus Serotype 2 to Enhance Infection of Mosquito Midguts.
Erb S, Butrapet S, Roehrig J, Huang C, Blair C Viruses. 2022; 14(7).
PMID: 35891549 PMC: 9325310. DOI: 10.3390/v14071569.
New mouse model for dengue virus vaccine testing.
Johnson A, Roehrig J J Virol. 1998; 73(1):783-6.
PMID: 9847388 PMC: 103889. DOI: 10.1128/JVI.73.1.783-786.1999.
Stocks C, Lobigs M J Virol. 1998; 72(3):2141-9.
PMID: 9499070 PMC: 109509. DOI: 10.1128/JVI.72.3.2141-2149.1998.
Lanar D, Tine J, de Taisne C, Seguin M, Cox W, Winslow J Infect Immun. 1996; 64(5):1666-71.
PMID: 8613376 PMC: 173977. DOI: 10.1128/iai.64.5.1666-1671.1996.
Shiu S, Ip K, Gould E, Chan K Arch Virol. 1993; 131(3-4):447-54.
PMID: 8347083 DOI: 10.1007/BF01378645.